InflaRx NV (IFRX)

1.89 -0.04 (-2.07%) USD  |  NASDAQ  |  Sep 25, 16:00
1.885 0.00 (0.00%) After-Hours: 19:59
More

InflaRx Cash and Short Term Investments (Annual) : 54.56M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for IFRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2015. Start Trial.
Date Value
December 31, 2025 54.56M
December 31, 2024 54.71M
December 31, 2023 99.72M
December 31, 2022 86.53M
December 31, 2021 94.86M
December 31, 2020 99.27M
Date Value
December 31, 2019 129.63M
December 31, 2018 178.98M
December 31, 2017 148.04M
December 31, 2016 30.71M
December 31, 2015 3.587M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
MediGene AG --
BioNTech SE 17.43B
Immatics NV 551.21M
Beam Therapeutics, Inc. 1.245B
Kymera Therapeutics, Inc. 848.28M